P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates

Drug Resistance Updates

Volumn 1, Issue 6, 1998, Pages 389-396

  Plowe, Christopher V ^a   Kublin, James G ^a   Doumbo, Ogobara K ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BAMAKO   (Mali)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77949634490     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-7646(98)80014-9     Document Type: Review

References (60)

1. Peters W. Chemotherapy and Drug Resistance in Malaria (1987), Academic Press, London
2. Jones A.S. Mass treatment with pyrimethamine. A study of resistance and cross resistance resulting from a field trial in the hyperendemic malarious area of Makueni, Kenya, September 1952-September 1953. Trans R Soc Trop Med Hyg 52 (1958) 547
3. World Health Organization Technical Report Series: Malaria Chemotherapy (1990), World Health Organization, Geneva
4. Radloff P.D., Philipps J., Nkeyi M., et al. Atovaquone and proguanil for Plasmodium falciparum malaria. Lancet 347 (1996) 1511-1514
5. Amukoye E., Winstanley P.A., Watkins W.M., et al. Chlorproguanildapsone: an effective treatment for uncomplicated falciparum malaria. Antimicrob Agents Chemother 41 (1997) 2261-2264
6. Rieckmann K.H., Yeo A.E., and Edstein M.D. Activity of PS-15 and its metabolite, WR99210, against Plasmodium falciparum in an in vivo-in vitro model. Trans R Soc Trop Med Hyg 90 (1996) 568-571
7. Plowe C.V., Djimde A., Bouare M., et al. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg 52 (1995) 565-568
8. Nguyen-Dinh P., and Payne D. Pyrimethamine sensitivity in Plasmodium falciparum: determination in vitro by a modified 48-hour test. Bull World Health Organ 58 (1980) 909-912
9. (in press). Triglia T., and Cowman A.F. The mechanism of resistance to sulfa drugs in Plasmodium falciparum. Drug Resistance Updates (1998)
10. Sirawaraporn W. Dihydrofolate reductase and antifolate resistance in malaria. Drug Resistance Updates 1 (1998) 397-406
11. Peterson D.S., Walliker D., and Wellems T.E. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc Natl Acad Sci USA 85 (1988) 9114-9118
12. Cowman A.F., Morry M.J., Biggs B.A., et al. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc Natl Acad Sci USA 85 (1988) 9109-9113
13. Snewin V.A., England S.M., Sims P.F., and Hyde J.E. Characterisation of the dihydrofolate reductase-thymidylate synthetase gene from human malaria parasites highly resistant to pyrimethamine. Gene 76 (1989) 41-52
14. Zolg J.W., Plitt J.R., Chen G.X., and Palmer S. Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis for pyrimethamine resistance in Plasmodium falciparum. Mol Biochem Parasitol 36 (1989) 253-262
15. Peterson D.S., Milhous W.K., and Wellems T.E. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proc Natl Acad Sci USA 87 (1990) 3018-3022
16. Foote S.J., Galatis D., and Cowman A.F. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc Natl Acad Sci USA 87 (1990) 3014-3017
17. Brooks D.R., Wang P., Read M., et al. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur J Biochem 224 (1994) 397-405
18. Triglia T., and Cowman A.F. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proc Natl Acad Sci USA 91 (1994) 7149-7153
19. Wang P., Read M., Sims P.F., and Hyde J.E. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization. Molec Microbiol 23 (1997) 979-986
20. Triglia T., Menting J.G.T., Wilson C., et al. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc Natl Acad Sci USA 94 (1997) 13944-13949
21. Wu Y., Kirkman L.A., and Wellems T.E. Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine. Proc Natl Acad Sci USA 93 (1996) 1130-1134
22. Triglia T., Wang P., Sims P.G., et al. Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihyropteroate synthase in sulfadoxine-resistant malaria. EMBO J 17 (1998) 3807-3815
23. Plowe C.V., Cortese J.F., Djimde A., et al. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J Infect Dis 176 (1997) 1590-1596
24. Wang P., Lee C.-S., Bayoumi R., et al. Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. Mol Biochem Parasitol 89 (1997) 161-177
25. Gyang F.N., Peterson D.S., and Wellems T.E. Plasmodium falciparum: rapid detection of dihydrofolate reductase mutations that confer resistance to cycloguanil and pyrimethamine. Exp Parasitol 74 (1992) 470-472
26. Duraisingh M.T., Curtis J., Warhurst D.C., et al. Plasmodium falciparum - detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. Exp Parasitol 89 (1998) 1-8
27. Peterson D.S., Di Santi S.M., Povoa M., et al. Prevalence of the dihydrofolate reductase Asn-108 mutation as the basis for pyrimethamine-resistant falciparum malaria in the Brazilian Amazon. Am J Trop Med Hyg 45 (1991) 492-497
28. Wang P., Brooks D.R., Sims P.F., and Hyde J.E. A mutation-specific PCR system to detect sequence variation in the dihydropteroate synthetase gene of Plasmodium falciparum. Mol Biochem Parasitol 71 (1995) 115-125
29. Shaio M.F., Wang P., Lee C.S., et al. Development and comparison of quantitative assays for the dihydropteroate synthetase codon 540 mutation associated with sulfadoxine resistance in Plasmodium falciparum. Parasitology 116 (1998) 203-210
30. Plowe C.V., Djimde A., Wellems T.E., et al. Community pyrimethamine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: A model for deterring resistance. Am J Trop Med Hyg 55 (1996) 467-471
31. Curtis J., Duraisingh M.T., Trigg J.K., et al. Direct evidence that asparagine at position 108 of the Plasmodium falciparum dihydrofolate reductase is involved in resistance to antifolate drugs in Tanzania. Trans R Soc Trop Med Hyg 90 (1996) 678-680
32. Edoh D., Mshinda H., Jenkins J., and Burger M. Pyrimethamine-resistant Plasmodium falciparum parasites among Tanzanian children: A facility-based study using the polymerase chain reaction. Am J Trop Med Hyg 57 (1997) 342-347
33. Nguyen-Dinh P., Spencer H.C., Chemangey-Masaba S., and Churchill F.C. Susceptibility of Plasmodium falciparum to pyrimethamine and sulfadoxine/pyrimethamine in Kisumu, Kenya. Lancet 1 (1982) 823-825
34. Schapira A., Bygbjerg I.C., Jepsen S., et al. The susceptibility of Plasmodium falciparum to sulfadoxine and pyrimethamine: correlation of in vivo and in vitro results. Am J Trop Med Hyg 35 (1986) 239-245
35. Watkins W.M., Mberu E.K., Winstanley P.A., and Plowe C.V. The efficacy of antifolate antimalarial combinations in Africa: A predictive model based on pharmadocynamic and pharmacokinetic analyses. parasitol Today 13 (1997) 459-464
36. Chulay J.D., Watkins W.M., and Sixsmith D.G. Synergistic antimalarial activity of pyrimethamine and sulfadoxine against Plasmodium falciparum in vitro. Am J Trop Med Hyg 33 (1984) 325-330
37. Krungkrai J., Webster H.K., and Yuthavong Y. De novo and salvage biosynthesis of pteroylpentaglutamates in the human malaria parasite, Plasmodium falciparum. Mol Biochem Parasitol 32 (1989) 25-37
38. van Hensbroek M.B., Morris-Jones S., Meisner S., et al. Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malaria. Trans R Soc Trop Med Hyg 89 (1995) 672-676
39. Suppl. Marsh K. Malaria- a neglected disease?. Parasitology 104 (1992) S53-S69
40. Baird J.K., Basri H., Jones T.R., et al. Resistance to antimalarials by Plasmodium falciparum in Arso PIR, Irian Jaya, Indonesia. Am J Trop Med Hyg 44 (1991) 640-644
41. Watkins W.M., Mberu E.K., Nevill C.G., et al. Variability in the metabolism of proguanil to the active metabolite cycloguanil in healthy Kenyan adults. Trans R Soc Trop Med Hyg 84 (1990) 492-495
42. Advances in Malaria Chemotherapy 711 (1984), World Health Organization, Geneva 29
43. Plowe C.V., Djimde A., Wellems T.E., et al. Community pyrimethamine-sulfadoxine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: a model for deterring resistance. Am J Trop Med Hyg 55 (1996) 467-471
44. (in press). Diourte Y., Djimde A., Doumbo O.K., et al. Pyrimethamine-sulfadoxine efficacy and selection for mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase in Mali. Am J Trop Med Hyg (1998)
45. Jelinek T., Ronn A.M., Curtis J., et al. High prevalence of mutations in the dihydrofolate reductase gene of Plasmodium falciparum in isolates from Tanzania without evidence of an association to clinical sulfadoxine/pyrimethamine resistance. Trop Med Int Health 2 (1997) 1075-1079
46. Basco L.K., Eldin de Pecoulas P., Wilson C.M., et al. Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Mol Biochem Parasitol 69 (1995) 135-138
47. Reeder J.C., Rieckmann K.H., Genton B., et al. Point mutations in the dihydrofolate reductase and dihydropteroate synthatase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea. Am J Trop Med Hyg 55 (1996) 209-213
48. Basco L.K., and Ringwald P. Molecular epidemiology of malaria in Yaounde, Cameroon II. Baseline frequency of point mutations in the dihydropteroate synthase gene of Plasmodium falciparum. Am J Trop Med Hyg 58 (1998) 374-377
49. Basco L.K., and Ringwald P. Molecular epidemiology of malaria in Yaounde, Cameroon I. Analysis of point mutations in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Am J Trop Med Hyg 58 (1998) 369-373
50. Zindrou S., Dung N.P., Sy N.D., et al. Plasmodium falciparum: Mutation pattern in the dihydrofolate reductase-thymidylate synthase genes of Vietnamese isolates, a novel mutation, and coexistence of two clones in a Thai patient. Exp Parasitol 84 (1996) 56-64
51. Kublin J.G., Witzig R.S., Shankar A.H., et al. Molecular assays for surveillance of antifolate-resistant malaria. Lancet 351 (1998) 1629-1630
52. Cortese J.F., and Plowe C.V. Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutants expressed in yeast. Mol Biochem Parasitol 94 (1998) 205-214
53. Clyde D.F., and Shute G.T. Resistance of Plasmodium falciparum in Tanganyika to pyrimethamine administered at weekly intervals. Trans R Soc Trop Med Hyg 51 (1957) 505-513
54. Watkins W.M., and Mosobo M. Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life. Trans R Soc Trop Med Hyg 87 (1993) 75-78
55. Schultz L.J., Steketee R.W., Macheso A., et al. The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am J Trop Med Hyg 51 (1994) 515-522
56. Curtis J., Duraisingh M.T., and Warhurst D.C. In vivo selection for a specific genotype of dihydropteroate synthetase of Plasmodium falciparum by pyrimethamine-sulfadoxine but not chlorproguanildapsone treatment. J Infect Dis 177 (1998) 1429-1433
57. Sirawaraporn W., Sathitkul T., Sirawaraporn R., et al. Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. Proc Natl Acad Sci USA 94 (1997) 1124-1129
58. Paul R.E., Packer M.J., Walmsley M., et al. Mating patterns in malaria parasite populations of Papua New Guinea. Science 269 (1995) 1709-1711
59. Mackinnon M.J. Survival probability of drug resistant mutants in malaria parasites. Proceedings of the Royal Society of London - Series B: Biological Sciences (1997) 53-59
60. Pablos-Mendez A., Raviglione M.C., Laszlo A., et al. Global surveillance for antituberculosis-drug resistance, 1994-1997. N Engl J Med 338 (1998) 1641-1649